Clinical trial at Södersjukhuset begins – the last step in the CE mark process
Today, Calmark Sweden AB announces the start of the clinical trial to support the CE Mark approval of the company’s bilirubin test. The trial is commencing in cooperation with the research entity of the children's hospital Sachsska barn- och ungdomssjukhuset, a part of Södersjukhuset. The trial has been approved by the hospital’s legal department, which means that it formally can be launched. The trial is expected to be finished before the end of the year.The trial is designed as a method-comparison study, where bilirubin analyzed with Calmark Neo is compared with the hospital laboratory’s